Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert Desnick
Icahn School of Medicine at Mount Sinai, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Recordati Rare Diseases
Other : Payment for services (e.g., consulting fees, honoraria, paid authorship) - (this option did not appear in dropdown menu)
Dr. Robert Desnick (Principal Investigator and Dean of the Department of Genetics and Genomic Sciences) receives financial compensation as a consultant for Alnylam Pharmaceuticals. Dr. Desnick also receives financial compensation as a consultant for Recordati Rare Diseases, a company which manufactures drugs for the treatment of acute porphyria. In addition, Dr. Desnick is a named inventor on a patent filed through Mount Sinai and licensed to Alnylam relating to the treatment of acute porphyria.
Heme Biosynthesis and the Porphyrias: Recent Advances
A two-day Research Conference is proposed for January 13-14, 2018 in Atlanta, Georgia. This conference will focus specifically on mammalian heme biosynthesis and the human porphyrias. In addition to the latest research presented by international expert investigators, a meeting focus will be discussing current unresolved knowledge gaps to stimulate future collaborative research. A large part of our Conference will be dedicated to career development for trainees and engaging them in these fields of research.
Filed on August 08, 2017.
Tell us what you know about Robert Desnick's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Robert Desnick filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Robert Desnick | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Recordati Rare Diseases | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.